BMC Medical Co., Ltd. (SHE:301367)
China
· Delayed Price · Currency is CNY 73.08
+1.50 (2.10%)
At close: Apr 30, 2025, 2:57 PM CST
BMC Medical Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2018 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Apr '25 Apr 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | 2018 - 2019 |
| Market Capitalization | 6,497 | 5,601 | 7,792 | 14,052 | - | - | Upgrade
|
| Market Cap Growth | 29.03% | -28.12% | -44.55% | - | - | - | Upgrade
|
| Enterprise Value | 4,015 | 3,021 | 5,363 | 13,467 | - | - | Upgrade
|
| Last Close Price | 73.08 | 63.00 | 85.89 | 153.43 | - | - | Upgrade
|
| PE Ratio | 36.79 | 36.05 | 26.21 | 36.95 | - | - | Upgrade
|
| Forward PE | 35.30 | 23.74 | 32.85 | 29.83 | - | - | Upgrade
|
| PS Ratio | 7.09 | 6.64 | 6.94 | 9.93 | - | - | Upgrade
|
| PB Ratio | 2.24 | 1.97 | 2.80 | 5.37 | - | - | Upgrade
|
| P/TBV Ratio | 2.25 | 1.98 | 2.81 | 5.40 | - | - | Upgrade
|
| P/FCF Ratio | 62.25 | 40.54 | 61.36 | 39.98 | - | - | Upgrade
|
| P/OCF Ratio | 54.07 | 36.35 | 51.57 | 37.45 | - | - | Upgrade
|
| PEG Ratio | - | 1.56 | 0.48 | 0.44 | - | - | Upgrade
|
| EV/Sales Ratio | 4.38 | 3.58 | 4.78 | 9.52 | - | - | Upgrade
|
| EV/EBITDA Ratio | 29.49 | 27.81 | 19.54 | 33.35 | - | - | Upgrade
|
| EV/EBIT Ratio | 35.01 | 31.15 | 20.27 | 33.82 | - | - | Upgrade
|
| EV/FCF Ratio | 38.47 | 21.87 | 42.23 | 38.32 | - | - | Upgrade
|
| Debt / Equity Ratio | 0.11 | 0.14 | 0.01 | 0.01 | 0.01 | - | Upgrade
|
| Debt / EBITDA Ratio | 2.33 | 3.41 | 0.09 | 0.05 | 0.03 | - | Upgrade
|
| Debt / FCF Ratio | 3.03 | 2.92 | 0.21 | 0.06 | 0.04 | - | Upgrade
|
| Asset Turnover | 0.29 | 0.27 | 0.38 | 0.80 | 1.22 | 1.70 | Upgrade
|
| Inventory Turnover | 5.40 | 4.08 | 3.86 | 5.17 | 4.59 | 5.28 | Upgrade
|
| Quick Ratio | 6.37 | 5.19 | 23.65 | 9.06 | 3.44 | 4.49 | Upgrade
|
| Current Ratio | 6.60 | 5.42 | 24.86 | 9.85 | 4.59 | 5.17 | Upgrade
|
| Return on Equity (ROE) | 6.30% | 5.64% | 11.10% | 24.52% | 33.66% | 86.16% | Upgrade
|
| Return on Assets (ROA) | 2.25% | 1.91% | 5.66% | 14.02% | 17.35% | 49.43% | Upgrade
|
| Return on Capital (ROIC) | 2.36% | 2.00% | 6.07% | 15.88% | 21.63% | 61.61% | Upgrade
|
| Return on Capital Employed (ROCE) | 3.90% | 3.40% | 9.40% | 15.10% | 30.40% | 69.30% | Upgrade
|
| Earnings Yield | 2.73% | 2.77% | 3.82% | 2.71% | - | - | Upgrade
|
| FCF Yield | 1.61% | 2.47% | 1.63% | 2.50% | - | - | Upgrade
|
| Dividend Yield | 0.55% | 0.64% | 1.16% | 0.93% | - | - | Upgrade
|
| Payout Ratio | 37.79% | 42.34% | 43.05% | - | 19.77% | 5.29% | Upgrade
|
| Buyback Yield / Dilution | 0.11% | 0.29% | -26.33% | -5.67% | 0.16% | -1559.19% | Upgrade
|
| Total Shareholder Return | 0.66% | 0.92% | -25.17% | -4.74% | 0.16% | -1559.19% | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.